BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31678784)

  • 1. Targeting phosphatidylethanolamine and phosphatidylserine for imaging apoptosis in cancer.
    Li J; Gray BD; Pak KY; Ng CK
    Nucl Med Biol; 2019; 78-79():23-30. PubMed ID: 31678784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of (18)F-dipicolylamine (DPA) derivatives in cells infected with influenza virus.
    Li J; Gerlach RL; Jonsson CB; Gray BD; Pak KY; Ng CK
    Nucl Med Biol; 2015 Mar; 42(3):283-91. PubMed ID: 25537726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Phosphatidylethanolamine with Fluorine-18 Labeled Small Molecule Probe for Apoptosis Imaging.
    Yuan G; Liu S; Ma H; Su S; Wen F; Tang X; Zhang Z; Zhao J; Lin L; Xiang X; Nie D; Tang G
    Mol Imaging Biol; 2020 Aug; 22(4):914-923. PubMed ID: 31828718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake and Reduced Nontarget Organ Radiation Burden.
    Kawai H; Chaudhry F; Shekhar A; Petrov A; Nakahara T; Tanimoto T; Kim D; Chen J; Lebeche D; Blankenberg FG; Pak KY; Kolodgie FD; Virmani R; Sengupta P; Narula N; Hajjar RJ; Strauss HW; Narula J
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1823-1833. PubMed ID: 29454770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmacological evaluation of (18)F-labeled phosphatidylserine-binding peptides for molecular imaging of apoptosis.
    Wuest M; Perreault A; Kapty J; Richter S; Foerster C; Bergman C; Way J; Mercer J; Wuest F
    Nucl Med Biol; 2015 Nov; 42(11):864-74. PubMed ID: 26205076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry.
    Chaudhry F; Kawai H; Johnson KW; Narula N; Shekhar A; Chaudhry F; Nakahara T; Tanimoto T; Kim D; Adapoe MKMY; Blankenberg FG; Mattis JA; Pak KY; Levy PD; Ozaki Y; Arbustini E; Strauss HW; Petrov A; Fuster V; Narula J
    J Am Coll Cardiol; 2020 Oct; 76(16):1862-1874. PubMed ID: 33059832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe.
    Zhao M; Li Z; Bugenhagen S
    J Nucl Med; 2008 Aug; 49(8):1345-52. PubMed ID: 18632826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Phosphatidylserine with a
    Perreault A; Richter S; Bergman C; Wuest M; Wuest F
    Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duramycin-porphyrin conjugates for targeting of tumour cells using photodynamic therapy.
    Broughton LJ; Giuntini F; Savoie H; Bryden F; Boyle RW; Maraveyas A; Madden LA
    J Photochem Photobiol B; 2016 Oct; 163():374-84. PubMed ID: 27619739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.
    Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM
    Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylethanolamine is externalized at the surface of microparticles.
    Larson MC; Woodliff JE; Hillery CA; Kearl TJ; Zhao M
    Biochim Biophys Acta; 2012 Dec; 1821(12):1501-7. PubMed ID: 22960380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylethanolamine targeting for cell death imaging in early treatment response evaluation and disease diagnosis.
    Elvas F; Stroobants S; Wyffels L
    Apoptosis; 2017 Aug; 22(8):971-987. PubMed ID: 28623512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.
    Wuest M; Perreault A; Richter S; Knight JC; Wuest F
    Apoptosis; 2019 Apr; 24(3-4):221-244. PubMed ID: 30684144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duramycin exhibits antiproliferative properties and induces apoptosis in tumour cells.
    Yates KR; Welsh J; Udegbunam NO; Greenman J; Maraveyas A; Madden LA
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):396-401. PubMed ID: 22543977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin.
    Audi S; Li Z; Capacete J; Liu Y; Fang W; Shu LG; Zhao M
    Nucl Med Biol; 2012 Aug; 39(6):821-5. PubMed ID: 22534031
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
    J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Li Y; Liu C; Xu X; Lu X; Luo J; Gray B; Pak KY; Cheng J; Zhang Y
    Nucl Med Biol; 2018 Nov; 66():18-25. PubMed ID: 30170197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses.
    Richard AS; Zhang A; Park SJ; Farzan M; Zong M; Choe H
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14682-7. PubMed ID: 26575624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes Containing Lipid-Soluble Zn(II)-Bis-dipicolylamine Derivatives Show Potential To Be Targeted to Phosphatidylserine on the Surface of Cancer Cells.
    Ayesa U; Gray BD; Pak KY; Chong PL
    Mol Pharm; 2017 Jan; 14(1):147-156. PubMed ID: 28043132
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.